e-Article
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
Document Type
Article
Author
Source
In Kidney International June 2024 105(6):1306-1315
Subject
Language
ISSN
0085-2538